We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The SEC has charged former Sangamo BioSciences executive Winson Tang with insider trading. Tang is accused of telling a friend about a 2014 agreement between Sangamo and Biogen before the news became public.